PET Total Lesion Glycolysis (TLG)

ورودی‌های بالینی بیمار

حداقل ۰.۱ — حداکثر ۱۰۰۰۰ • واحد: mL

حداقل ۰.۱ — حداکثر ۱۰۰

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
tlg
—g
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Low TLG0–100
  • Moderate TLG100–500
  • High TLG≥ 500
Direct Clinical Answer

The PET Total Lesion Glycolysis (TLG) calculates staging malignant disease, estimating overall survival, and assessing chemotherapy tolerability. Key inputs include metabolic tumor volume. Scores guide adjusting systemic antineoplastic regimens, planning supportive palliative measures, or targeted monitoring. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Total lesion glycolysis: metabolic tumor volume multiplied by mean SUV. Prognostic PET metric in oncology.

Clinical Indication

The PET Total Lesion Glycolysis (TLG) is indicated for bedside clinical practice to support Total lesion glycolysis: metabolic tumor volume multiplied by mean SUV. Prognostic PET metric in oncology.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients with solid tumors or hematologic malignancies undergoing staging, systemic therapy tolerability assessment, or prognostic stratification. Clinical application is indicated across Medical oncology clinics, chemotherapy infusion suites, inpatient oncology services, and palliative care.

Limitations & Contraindications

Prognostic indices provide statistical cohort survival estimates and must not replace individualized patient goals of care.

Clinical Pearls & Action Plan

Standardized functional performance status (ECOG or Karnofsky) is an independent determinant of chemotherapy tolerance and survival.

Formula & Variables:

TLG = Metabolic Tumor Volume (mL) x SUVmean

Input Parameters

NameTypeRequiredDescription
metabolic_tumor_volumefloatYesMetabolic tumor volume(mL)
suv_meanfloatYesMean standardized uptake value

Score Interpretation & Guidance

RangeStageDescription
0–100Low TLGRelatively low total lesion glycolysis
100–500Moderate TLGModerate total lesion glycolysis
≥ 500High TLGHigh total lesion glycolysis

Evidence-Based References (EBM)

  • Larson SM, Erdi Y, Akhurst T, et al. Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging. Clin Positron Imaging. 1999;2(3):159-171.

Related calculators